EyePoint Pharmaceuticals Stock (NASDAQ: EYPT) stock price, news, charts, stock research, profile.
Open | $12.200 |
Close | - |
Volume / Avg. | 579.481K / 1.162M |
Day Range | 12.000 - 12.510 |
52 Wk Range | 5.670 - 30.990 |
Market Cap | $629.437M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 33 |
Short Interest | 14.78% |
Days to Cover | 11.63 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of EyePoint Pharmaceuticals (NASDAQ: EYPT) through any online brokerage.
Other companies in EyePoint Pharmaceuticals’s space includes: Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL) and WAVE Life Sciences (NASDAQ:WVE).
The latest price target for EyePoint Pharmaceuticals (NASDAQ: EYPT) was reported by HC Wainwright & Co. on Monday, May 13, 2024. The analyst firm set a price target for 30.00 expecting EYPT to rise to within 12 months (a possible 148.24% upside). 25 analyst firms have reported ratings in the last year.
The stock price for EyePoint Pharmaceuticals (NASDAQ: EYPT) is $12.085 last updated Today at May 13, 2024 at 12:39 PM EDT.
There are no upcoming dividends for EyePoint Pharmaceuticals.
EyePoint Pharmaceuticals’s Q2 earnings are confirmed for Wednesday, July 31, 2024.
There is no upcoming split for EyePoint Pharmaceuticals.
EyePoint Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.